NCT04285346View on ClinicalTrials.gov

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

June 25, 2021

Study Completion Date

August 30, 2022

Conditions
Tuberous Sclerosis
Interventions
DRUG

Ganaxolone

titration followed by maintenance and extension period

Trial Locations (7)

27710

Marinus Research Site, Durham

45229

Marinus Research Site, Cincinnati

77030

Marinus Research Site, Houston

90095

Marinus Research Site, Los Angeles

94304

Marinus Research Site, Palo Alto

02115

Marinus Research Site, Boston

07039

Marinus Research Site, Livingston

Sponsors
All Listed Sponsors
lead

Marinus Pharmaceuticals

INDUSTRY

NCT04285346 - Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) | Biotech Hunter | Biotech Hunter